GSTC (GlobeStar Therapeutics) Interest Expense: $-0.08 Mil (TTM As of Jun. 2024)


What is GlobeStar Therapeutics Interest Expense?

GlobeStar Therapeutics GSTC -99.00% Interest Expense is $-0.08 Mil as of Jun. 2024.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. GlobeStar Therapeutics's interest expense for the three months ended in Jun. 2024 was $ -0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2024 was $-0.08 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. GlobeStar Therapeutics's Operating Income for the three months ended in Jun. 2024 was $ -0.19 Mil. GlobeStar Therapeutics's Interest Expense for the three months ended in Jun. 2024 was $ -0.00 Mil. GlobeStar Therapeutics did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

GlobeStar Therapeutics  (OTCPK:GSTC) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

GlobeStar Therapeutics's Interest Expense for the three months ended in Jun. 2024 was $-0.00 Mil. Its Operating Income for the three months ended in Jun. 2024 was $-0.19 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Jun. 2024 was $0.00 Mil.

GlobeStar Therapeutics's Interest Coverage for the quarter that ended in Jun. 2024 is calculated as

GlobeStar Therapeutics did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

GlobeStar Therapeutics Interest Expense Historical Data

* Premium members only.

The historical data trend for GlobeStar Therapeutics's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GlobeStar Therapeutics Interest Expense Chart

GlobeStar Therapeutics Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.36 -0.24 -0.29 -0.07 -0.09

GlobeStar Therapeutics Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 -0.06 -0.01 -0.01 -0.00

GlobeStar Therapeutics Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.08 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of $-0.08 Mil mean?
GlobeStar Therapeutics (GSTC) has a Interest Expense of $-0.08 Mil as of Jun. 2024. Interest Expense is the amount a company pays on its long-term debt. View historical data on GlobeStar Therapeutics and its competitors.
Is GlobeStar Therapeutics' Interest Expense too high?
GlobeStar Therapeutics' current Interest Expense is $-0.08 Mil.
How does GlobeStar Therapeutics' Interest Expense compare to GBLX and ENDV?
GlobeStar Therapeutics' Interest Expense of $-0.08 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Biotechnology company?
A good Interest Expense depends on the Biotechnology industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on GlobeStar Therapeutics and its competitors. GlobeStar Therapeutics's current Interest Expense is $-0.08 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GlobeStar Therapeutics stock overvalued right now?
GlobeStar Therapeutics (GSTC) has a current Interest Expense of $-0.08 Mil. The current Interest Expense is $-0.08 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For GlobeStar Therapeutics (GSTC), the current Interest Expense is $-0.08 Mil as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

GlobeStar Therapeutics Business Description

Address 719 Jadewin Avenue, Richland, WA, USA, 99352
GlobeStar Therapeutics Corp is a clinical-stage pharmaceutical company introducing a patented formulation of previously approved drugs for the treatment of Multiple Sclerosis. The company is focused on developing therapies for people with serious and life-threatening rare disorders.